Peter Hanlon on representation of older people in clinical trials
Get every episode summarized
Each time The Lancet Healthy Longevity in conversation with publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Dr Peter Hanlon talks with The Lancet Healthy Longevity about the representativeness of clinical trials done in older people.
Read the full article:
https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00092-1/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Get every episode summarized
Each time The Lancet Healthy Longevity in conversation with publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Lancet Healthy Longevity in conversation with
Ara Nazarian on musculoskeletal diseases in the USA
The Lancet Healthy Longevity in conversation with
Andrew Kingston on socioeconomic inequalities and disability
The Lancet Healthy Longevity in conversation with
Miles Witham on metformin to improve physical performance
The Lancet Healthy Longevity in conversation with
Harish Nair and Durga Kulkarni on the human metapneumovirus burden in older adul...
The Lancet Healthy Longevity in conversation with